Levobunolol Hydrochloride

CHEMBL1201177 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

327.8 g/mol

LogP

—

Phase

4

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

Molecular Weight

327.8000 g/mol

TPSA

58.60 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl

InChI

InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1

Molecular Formula

C17H26ClNO3

HBD / HBA

3 / 4

Rotatable Bonds

6

Heavy Atoms

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

Yes, Levobunolol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201177. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5284409. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Looking for patient-friendly information?

Levobunolol Hydrochloride on PillFYI

Structure

Quick Data

Formula: C17H26ClNO3

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.